
A true role model for academic success.
Inspires students to love their studies.
Creates a safe space for learning and growth.
Always goes the extra mile for students.
Great Professor!
Associate Professor David Newby is the Head of the Discipline of Pharmacy in the School of Biomedical Sciences and Pharmacy at the University of Newcastle, Australia, within the College of Health, Medicine and Wellbeing. He earned his PhD and Graduate Diploma in Epidemiology from the University of Newcastle and a Bachelor of Pharmacy from the University of South Australia. Newby began his career at the University of Newcastle in 1995 as a Clinical Evaluator in Clinical Pharmacology in the School of Medicine and Public Health. He progressed to Research Academic from 2002 to 2003, Senior Lecturer from 2003 to 2008, and Associate Professor in Clinical Pharmacology and Clinical Toxicology from 2008 to 2018. Since 2019, he has served as Associate Professor in the Discipline of Pharmacy and Experimental Pharmacology. He teaches evidence-based practice, pharmacoepidemiology, pharmacoeconomics, and clinical pharmacology in both medical and pharmacy courses, serving as a foundation lecturer in the Master of Pharmacy course and establishing its pharmacy practice component.
Newby's research focuses on decision making, information needs, pharmacoeconomics, pharmacoepidemiology, pharmacology, and pharmacy practice, utilizing qualitative and quantitative approaches including surveys, interviews, and focus group discussions. He is a Fellow of the Pharmaceutical Society of Australia since 2018 and has received the Outstanding Contribution to Student Learning award from the Australian Learning & Teaching Council in 2009 and the Vice-Chancellor's Award for Outstanding Contribution to Student Learning from the University of Newcastle in 2007. Additionally, he holds a ministerial appointment to the Pharmaceutical Benefits Advisory Committee. His key publications include co-authoring Community Pharmacy: Symptoms, Diagnosis and Treatment (2008, 2011, 2012, 2015 editions with P. Rutter) and Pharmacology for Pharmacy and the Health Sciences (2010, 2016, 2017 with M. Boarder and others). He has contributed book chapters on topics such as women's health, paediatrics, gastroenterology, and evidence-based pharmacy practice, along with conference papers on interprofessional learning, pharmacogenomics of antidepressants, and diabetes risk assessment in community pharmacy.